Status:
COMPLETED
The Effect of Aromatherapy Massage Applied to Hemodialysis Patients With Muscle Cramp
Lead Sponsor:
TC Erciyes University
Conditions:
Muscle Cramps
Aromatherapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a randomized controlled and single-blind study consisting of qualitative and quantitative stages to evaluate the effect of aromatherapy massage on cramp frequency, cramp pain severity an...
Detailed Description
Data-collecting interviewers are blind to which patients are in which group. The days and sessions of the groups were randomly determined after patients meeting the research criteria of the interventi...
Eligibility Criteria
Inclusion
- Above 18 years old,
- Able to answer questions and communicate,
- Is conscious and does not have a mental problem,
- Speaks Turkish,
- No hearing, sight or speech impairment,
- Having HD treatment for at least six months,
- Receiving three HD treatment sessions a week,
- Dialysis with bicarbonate dialysate,
- Kt / V value\> 1.2,
- Having a constant dry weight for the last month,
- Experiencing cramps during hemodialysis sessions or at any other time and who scored at least three or more when the severity of cramp pain was evaluated with the Visual Analog Scale (VAS),
- Patients who are not allergic to the oils used for massage will be included in the study.
Exclusion
- Pregnant and breastfeeding women,
- Cancer,
- Diabetic foot,
- Lower extremity amputation,
- Having neurological diseases such as epilepsy, parkinson, dementia, Alzheimer,
- Those with paraplegia,
- The lower leg is in a size that prevents the application of massage,
- had surgery in the last three months,
- Loss of sensation more than 50% due to neuropathy due to various reasons,
- Open wound in the foot and lower leg, infection, necrosis, fracture / fracture suspected, soft tissue damage, burn,
- Peripheral vascular disease,
- Deep vein thrombosis,
- Receiving treatment to prevent cramping,
- Having a severe electrolyte (such as potassium, magnesium, calcium) disorder in blood values,
- Patients using any of the complementary and integrated methods in the last month will not be included in the study.
Key Trial Info
Start Date :
November 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2022
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04874857
Start Date
November 25 2020
End Date
December 28 2022
Last Update
January 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erciyes University
Melikgazi, Kayseri, Turkey (Türkiye), 38260